Drew Cotter

Drew Cotter possesses extensive experience in regulatory affairs and project management within the tobacco and biomedical sectors. Currently serving as a Director at Altria since September 2016, Drew has held several leadership roles focused on pre-market regulatory clearance for new and modified risk tobacco products. Prior experience includes strategic project management at Lancaster Laboratories, overseeing regulatory submissions for modified risk product claims, and various roles at LifeNet, where Drew led the development of osteobiologic products. Educational credentials include an MBA from William & Mary and a BS in Biomedical Engineering from Virginia Commonwealth University.